192 related articles for article (PubMed ID: 33346545)
1. Bisphosphonate-Related Osteonecrosis of the Jaw.
Chien HI; Chen LW; Liu WC; Lin CT; Ho YY; Tsai WH; Yang KC
Ann Plast Surg; 2021 Feb; 86(2S Suppl 1):S78-S83. PubMed ID: 33346545
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes.
O'Ryan FS; Lo JC
J Oral Maxillofac Surg; 2012 Aug; 70(8):1844-53. PubMed ID: 22595135
[TBL] [Abstract][Full Text] [Related]
3. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC
J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
[TBL] [Abstract][Full Text] [Related]
4. Osteonecrosis of the jaw and nonmalignant disease: is there an association with rheumatoid arthritis?
Lescaille G; Coudert AE; Baaroun V; Javelot MJ; Cohen-Solal M; Berdal A; Goudot P; Azérad J; Ruhin B; Descroix V
J Rheumatol; 2013 Jun; 40(6):781-6. PubMed ID: 23504384
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients.
Thumbigere-Math V; Sabino MC; Gopalakrishnan R; Huckabay S; Dudek AZ; Basu S; Hughes PJ; Michalowicz BS; Leach JW; Swenson KK; Swift JQ; Adkinson C; Basi DL
J Oral Maxillofac Surg; 2009 Sep; 67(9):1904-13. PubMed ID: 19686928
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonate-related osteonecrosis of the jaws.
Kushner GM; Alpert B
Curr Opin Otolaryngol Head Neck Surg; 2011 Aug; 19(4):302-6. PubMed ID: 21677585
[TBL] [Abstract][Full Text] [Related]
7. Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development?
Otto S; Tröltzsch M; Jambrovic V; Panya S; Probst F; Ristow O; Ehrenfeld M; Pautke C
J Craniomaxillofac Surg; 2015 Jul; 43(6):847-54. PubMed ID: 25958767
[TBL] [Abstract][Full Text] [Related]
8. Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.
Assaf AT; Smeets R; Riecke B; Weise E; Gröbe A; Blessmann M; Steiner T; Wikner J; Friedrich RE; Heiland M; Hoelzle F; Gerhards F
Anticancer Res; 2013 Sep; 33(9):3917-24. PubMed ID: 24023329
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons.
Yoneda T; Hagino H; Sugimoto T; Ohta H; Takahashi S; Soen S; Taguchi A; Toyosawa S; Nagata T; Urade M
J Bone Miner Metab; 2010 Jul; 28(4):365-83. PubMed ID: 20333419
[TBL] [Abstract][Full Text] [Related]
10. Oral bisphosphonate-related osteonecrosis of the jaw: the first report in Asia.
Hong JW; Nam W; Cha IH; Chung SW; Choi HS; Kim KM; Kim KJ; Rhee Y; Lim SK
Osteoporos Int; 2010 May; 21(5):847-53. PubMed ID: 19633881
[TBL] [Abstract][Full Text] [Related]
11. Clinical profile of individuals with bisphosphonate-related osteonecrosis of the jaw: an integrative review.
Maciel AP; Quispe RA; Martins LJO; Caldas RJ; Santos PSDS
Sao Paulo Med J; 2020; 138(4):326-335. PubMed ID: 32725058
[TBL] [Abstract][Full Text] [Related]
12. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
[TBL] [Abstract][Full Text] [Related]
13. Zoledronate and osteonecrosis of the jaw in osteoporosis: incidence and risk factors. Analysis of the French Pharmacovigilance Database.
Amigues C; Fresse A; Roux CH; Gauthier S; Vieillard MH; Drici MD; Breuil V;
Joint Bone Spine; 2023 Dec; 90(6):105599. PubMed ID: 37271278
[TBL] [Abstract][Full Text] [Related]
14. Incidence and trend of antiresorptive agent-related osteonecrosis of the jaw from 2016 to 2020 in Kure, Japan.
Kunihara T; Tohmori H; Tsukamoto M; Kobayashi M; Okumura T; Teramoto H; Hamasaki T; Yamasaki T; Nakagawa T; Okimoto N; Fujiwara S
Osteoporos Int; 2023 Jun; 34(6):1101-1109. PubMed ID: 37002373
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of bisphosphonate-associated osteonecrosis of the jaw after intravenous zoledronate infusions in patients with early breast cancer.
Rugani P; Luschin G; Jakse N; Kirnbauer B; Lang U; Acham S
Clin Oral Investig; 2014; 18(2):401-7. PubMed ID: 23749244
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonate-related osteonecrosis of jaw (BRONJ) in Japanese population: a case series of 13 patients at our clinic.
Nomura T; Shibahara T; Uchiyama T; Yamamoto N; Shibui T; Yakushiji T; Watanabe A; Muramatsu K; Ogane S; Murayama M; Sekine R; Nakata E; Fujimoto Y
Bull Tokyo Dent Coll; 2013; 54(2):117-25. PubMed ID: 23903583
[TBL] [Abstract][Full Text] [Related]
17. National Survey on Bisphosphonate-Related Osteonecrosis of the Jaws in Japan.
Shibahara T; Morikawa T; Yago K; Kishimoto H; Imai Y; Kurita K
J Oral Maxillofac Surg; 2018 Oct; 76(10):2105-2112. PubMed ID: 29746838
[TBL] [Abstract][Full Text] [Related]
18. The national-scale cohort study on bisphosphonate-related osteonecrosis of the jaw in Taiwan.
Yuh DY; Chang TH; Huang RY; Chien WC; Lin FG; Fu E
J Dent; 2014 Oct; 42(10):1343-52. PubMed ID: 24907558
[TBL] [Abstract][Full Text] [Related]
19. Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: not just a sporadic coincidence--a multi-centre study.
Otto S; Abu-Id MH; Fedele S; Warnke PH; Becker ST; Kolk A; Mücke T; Mast G; Köhnke R; Volkmer E; Haasters F; Lieger O; Iizuka T; Porter S; Campisi G; Colella G; Ploder O; Neff A; Wiltfang J; Ehrenfeld M; Kreusch T; Wolff KD; Stürzenbaum SR; Schieker M; Pautke C
J Craniomaxillofac Surg; 2011 Jun; 39(4):272-7. PubMed ID: 20580566
[TBL] [Abstract][Full Text] [Related]
20. Osteonecrosis of the jaws in patients assuming oral bisphosphonates for osteoporosis: a retrospective multi-hospital-based study of 87 Italian cases.
Di Fede O; Fusco V; Matranga D; Solazzo L; Gabriele M; Gaeta GM; Favia G; Sprini D; Peluso F; Colella G; Vescovi P; Campisi G
Eur J Intern Med; 2013 Dec; 24(8):784-90. PubMed ID: 23768563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
